Inogen Inc (INGN): R&D Expense
$19.40M
Year ended 2025-12-31
$21.12M
Trailing 12 months to 2026-06-30
-4.0%
3-year compound annual growth
+6.6%
5-year compound annual growth
+16.6%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $19.40M | -10.2% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $21.61M | +3.7% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $20.84M | -5.0% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $21.94M | +32.4% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $16.58M | +17.7% | 2024-03-01, From 2021-01-01 |
| 2020-12-31 | $14.08M | +49.8% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $9.40M | +33.7% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $7.03M | +32.3% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $5.31M | +3.9% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $5.11M | +22.3% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $4.18M | +40.4% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $2.98M | +24.1% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $2.40M | +6.0% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $2.26M | n/a | 2015-04-27, From 2012-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Inogen Inc (INGN) | 2025-12-31 | $19.40M | -10.2% |
| Establishment Labs Holdings Inc. (ESTA) | 2025-12-31 | $20.25M | +2.7% |
| Cadre Holdings, Inc. (CDRE) | 2025-12-31 | $11.40M | +36.0% |
| Sanara MedTech Inc. (SMTI) | 2025-12-31 | $5.07M | +79.3% |
| MSA Safety Inc (MSA) | 2025-12-31 | $65.34M | -1.8% |
| Enovis Corp (ENOV) | 2025-12-31 | $120.33M | +31.8% |
| Myomo, Inc. (MYO) | 2025-12-31 | $6.94M | +45.5% |
| Align Technology Inc (ALGN) | 2025-12-31 | $369.91M | +1.6% |
| Lifeward Ltd. (LFWD) | 2025-12-31 | $3.25M | -29.8% |
Compare INGN, ESTA, CDRE, SMTI side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗